# Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients

> **NCT00292526** · PHASE4 · COMPLETED · sponsor: **European Institute of Oncology** · enrollment: 114 (actual)

## Conditions studied

- Cardiotoxicity
- Chemotherapeutic Toxicity

## Interventions

- **DRUG:** Enalapril

## Key facts

- **NCT ID:** NCT00292526
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-11
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292526, "Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00292526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*